Tap To Call

  Call 01908 799870

Spring Newsletter for APS Therapists

pageid: 1867

Happy Spring!

The newsletter for APS Therapists will be coming out soon, with stories and experiences from all kinds of conditions, including post-surgical, back pain, injuries, fractures and painful conditions. In the meantime,a growing number of MS Therapy Centres across the UK have been taking on APS Therapy, I thought you might like to see theirs. All the best for Less pain, More energy, & Faster healing for you and your clients!

Spasms, Botox and APS Therapy
APS Therapy assists in the removal of waste products from the body. We recently had a report from a client that the botox injections he has in his legs for spasticity, which normally lasted him well for 3 months, were becoming ineffective much faster – probably due to the APS Therapy doing what it says it will. We have a client who uses it for Bell’s Palsy and still successfully uses APS on the rest of his body, and someone who has not noticed any problem with her bladder botox when using APS for leg pain, but we now avoid treating any area that a person is successfully using Botox on.
Having said that, we’ve now had many people who use it for painful feet & legs, report that their spasms are also alleviated by the treatment, so in cases of painful or annoying intermittent spasms, it’s worth trialling a course of treatment. It’s included in my latest MS blog; Natural treatments for MS spasms, which includes a rough & ready video showing one of our users discussing this effect.
If you’d like to find out more about using APS Therapy at your centre, but are based at a distance, we can arrange a  webinar presentation or visit. Regular info sessions and training also take place at the Bedford MS Therapy Centre.
Call 01908 799870 and we’ll call you back.
Fatigue, post-relapse blues and APS 
During our first 18 months of getting good results for pain, we noticed that some people also had a significant improvement in energy levels/reduction in fatigue. We have now made treatment available for people with fatigue, and for those who have had a relapse, or are just generally struggling with malaise.We offer no guarantee, but have had some really powerful success stories, from young people struggling with severe post-relapse fatigue, to people who’ve had MS a very long time. We are now using the ‘Modified fatigue Impact Scale’ or MFIS as an outcome measure for people using APS for fatigue. You can access it here, from page 47 of thisdownloadTestimonials can be seen here, & include this from Maggie, who’s had MS for over 20 years:
“Pain during day virtually gone. Pain at night much reduced – now only troubling between 6-8am.Energy levels greatly improved. Much more stamina…

I can move around with ease and no longer have to plan everything I need to do. I can walk around the centre without a stick.

I can stand long enough to do some housework and get myself some lunch.

Mood- has elevated to new heights. I am delighted with the transformation – I feel I am getting me back.”

Presenting research
We’re very proud to be presenting results from our first 2 years of APS therapy at the Beds & Northants MS Therapy Centre, at the Consortium of MS Centres Annual Meeting in Maryland, USA, in June. Results were remarkable consistent with the first year’s data, showing 78% of people having a good response to treatment. We’d like to invite all centres now using APS Therapy to consent your patients to use their data in research, and keep outcomes measures. I hope that one day we may be able to get funding and put together a large, multicentre study, but in the meantime, all results are gratifying and interesting; please do get in touch to share your data.
Also excited to be taking part in the ‘MS Hackathon‘, a Dutch event where software designers, engineers and medical innovators are invited to spend 36 hours focussing their skills on innovating for MS, to design an app, software, to make life easier or solve some part of the problem of MS. We’re aiming to design an app to make the use of APS Therapy even more effective in MS. It’s a competition, so wish us luck, but whatever the outcome, we should come out with something exciting that can be used by our patients in the future. All the best, Miranda & team. 🙂